Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Philadelphia, PA
NPI
1578597209
Since 2006
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3401 Civic Center Blvd, Children's Hospital of Philadelphia - Neurology
Philadelphia, PA, 19104
Phone (215) 590-1719
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,546
34 services
Medicare patients, 2024
28
Average age 45
Drug cost, 2024
$10.0M
900 prescriptions
Company payments, 2025
$10K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David R Lynch was code 99214 (office e&m - established), 24 times for 21 patients. In total David R Lynch billed 34 services in 5 codes, and Medicare paid $2,546.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 24 | 21 | $80.61 | $1,935 |
By year: 2022 $2,638 for 40 services; 2023 $3,780 for 43 services; 2024 $2,546 for 34 services.
Medicare prescription drug claims, 2024
In 2024, the drug David R Lynch prescribed most often to Medicare patients was Skyclarys (Omaveloxolone), with 337 prescriptions and refills. In total David R Lynch wrote 900 Medicare prescriptions that cost $10.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Skyclarys Omaveloxolone | 337 | 337 | 39 | $10.0M |
| Baclofen Generic | 128 | 248 | 28 | $3,585 |
| Gabapentin Generic | 82 | 156 | 17 | $1,716 |
| Amantadine Amantadine Hcl | 47 | 99 | Under 11 | $1,743 |
| Citalopram Hbr Citalopram Hydrobromide | 32 | 60 | Under 11 | $271 |
| Levetiracetam Generic | 19 | 27 | Under 11 | $269 |
| Levocarnitine Generic | 15 | 23 | Under 11 | $2,450 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 13 | 17 | Under 11 | $629 |
| Primidone Generic | 13 | 19 | Under 11 | $114 |
| Riluzole Generic | 13 | 19 | Under 11 | $453 |
| Tizanidine Hcl Generic | 12 | 20 | Under 11 | $322 |
| Divalproex Sodium Generic | 12 | 12 | Under 11 | $129 |
| Clonazepam Generic | 11 | 15 | Under 11 | $268 |
Brand drugs: 341 claims; generic drugs: 559 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David R Lynch $10K ($9,704 in general payments such as food, travel and fees and $685 for research) from 3 companies. The largest payer was Biogen, Inc. with $10K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.